Second Sight Medical Products manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight.
Type
Public
HQ
Los Angeles, US
Founded
1998
Size (employees)
110 (est)
Second Sight Medical Products was founded in 1998 and is headquartered in Los Angeles, US
Report incorrect company information

Second Sight Medical Products Office Locations

Second Sight Medical Products has an office in Los Angeles
Los Angeles, US (HQ)
12477 San Fernando Rd
Show all (1)
Report incorrect company information

Second Sight Medical Products Financials and Metrics

Second Sight Medical Products Financials

Second Sight Medical Products's revenue was reported to be $7.96 m in FY, 2017
USD

Revenue (FY, 2017)

8 m

Gross profit (FY, 2017)

2.8 m

Gross profit margin (FY, 2017), %

35.7%

Net income (FY, 2017)

(28.5 m)

EBIT (FY, 2017)

(28.6 m)

Market capitalization (20-Apr-2018)

89.8 m

Cash (31-Dec-2017)

604 k
Second Sight Medical Products's current market capitalization is $89.8 m.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

9 m4 m8 m

Revenue growth, %

(55%)

Cost of goods sold

5.3 m10.1 m5.1 m

Gross profit

3.7 m(6.1 m)2.8 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.7 m2.7 m2.2 m1.1 k1 m1.2 m1 m2.2 m1.6 m

Cost of goods sold

1.3 m1.6 m757.1 k912 3.2 m2.6 m1.1 m1.1 m1 m

Gross profit

404.3 k1.1 m1.5 m141 (2.2 m)(1.4 m)(118 k)1.1 m609 k

Gross profit Margin, %

24%41%66%13%(213%)(122%)(12%)50%38%
Annual
USDFY, 2015FY, 2016FY, 2017

Cash

239 k539 k604 k

Accounts Receivable

1.5 m274 k1.8 m

Inventories

1.1 m717 k2.7 m

Current Assets

26.8 m15.3 m13.2 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

652.3 k407.4 k268.7 k459 184 k277 k266 k763 k639 k

Accounts Receivable

1.3 m1.2 m1.3 m822 677 k447 k782 k926 k668 k

Inventories

6.4 m6.8 m8.1 m9.1 k7.4 m5.8 m3.1 m3.1 m462 k

Current Assets

38.4 m35.7 m31.9 m21.1 k32.5 m24.7 m28.6 m22.8 m17.7 m
Annual
USDFY, 2015FY, 2016FY, 2017

Net Income

(20 m)(33.2 m)(28.5 m)

Depreciation and Amortization

335 k432 k

Inventories

(2.5 m)10 k3.9 m

Accounts Payable

197 k446 k(419 k)
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.5 m)(14.4 m)(6.7 m)

Inventories

1 m1.9 m462 k

Accounts Payable

414.4 k330.4 k544.4 k707 671 k694 k(269 k)(528 k)826 k

Cash From Operating Activities

(6.6 m)(12.6 m)
USDY, 2017

Revenue/Employee

70.7 k

Financial Leverage

1.8 x
Show all financial metrics

Second Sight Medical Products Operating Metrics

FY, 2016

Patents Issued

381

Patents Pending

126
Show all operating metrics
Report incorrect company information